Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2014-09-30 Share Issue/Capital Cha…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Number of shares and votes in Orexo
Share Issue/Capital Change Classification · 1% confidence The document is a short press release dated September 30, 2014, announcing a change in the total number of shares and votes in Orexo following a directed issue of new shares resolved on August 28, 2014. This directly relates to a change in the company's capital structure (share count). Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements detailing changes in the number of outstanding shares. It is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). The length is short, but the content is a direct announcement of a capital change, not just an announcement of a report publication (RPA/RNS).
2014-09-30 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated September 30, 2014, titled "Antal aktier och röster i Orexo" (Number of shares and votes in Orexo). It explicitly states that the total number of shares and votes has changed due to a directed new share issue decided on August 28, 2014, and reports the current total count (34,325,155). This content directly relates to changes in the company's capital structure and share count. This aligns best with the 'Share Issue/Capital Change' category (SHA). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a financing update (CAP) which usually implies fundraising activities rather than just reporting the resulting share count.
2014-09-30 Swedish
Orexo has successfully completed its private placement of approx. SEK 346.5m
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing the successful completion of a private placement of shares, raising approximately SEK 346.5m. Key phrases include 'private placement of approx. SEK 346.5m', 'issue 1,371,922 new Orexo shares', 'raise capital on favorable terms', and details about share dilution and settlement dates. This activity directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not an Earnings Release (ER) or an Interim Report (IR) as it focuses purely on the financing transaction.
2014-08-29 English
Orexo har framgångsrikt genomfört en placering om cirka 346,5 MSEK
Share Issue/Capital Change Classification · 1% confidence The document is a press release titled "Orexo har framgångsrikt genomfört en placering om cirka 346,5 MSEK" (Orexo has successfully completed a placement of approximately SEK 346.5 million). The content explicitly discusses the completion of a share placement involving both treasury shares and newly issued shares, setting a price via a bookbuilding procedure, and the resulting capital increase and dilution. This activity directly relates to fundraising, financing activities, and changes in the capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (11,692 chars) is substantial, confirming it is the primary announcement, not just a brief RPA.
2014-08-29 Swedish
Orexo intends to conduct a private placement of shares to Swedish and international institutional and strategic investors
Capital/Financing Update Classification · 1% confidence The document is a press release announcing Orexo's intention to conduct a 'private placement of shares' to institutional and strategic investors. This action directly relates to raising capital or changing the capital structure through the issuance of new or treasury shares. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). While it involves shares, it is an announcement of a financing event, not a general share issue/split (SHA) or a buyback (POS). It is not a full financial report (10-K, IR) or an earnings release (ER).
2014-08-28 English
Orexo avser att genomföra en placering av aktier till svenska och internationella institutionella och strategiska investerare
Capital/Financing Update Classification · 1% confidence The document is a press release from Orexo AB, dated August 28, 2014, announcing its intention to conduct a share placement (offering of shares) to institutional and strategic investors. The text explicitly mentions the process of setting the price via a 'bookbuilding-förfarande' and states the intended use of the proceeds (financing expansion). This activity directly relates to raising capital or changing the capital structure through the issuance of new shares or the sale of treasury shares. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it involves shares, it is an announcement of a financing event, not a general share issue/split (SHA) or a transaction in own shares (POS) in isolation, but rather a specific capital raise event.
2014-08-28 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.